Published in J Comput Aided Mol Des on December 06, 2005
Prediction of passive blood-brain partitioning: straightforward and effective classification models based on in silico derived physicochemical descriptors. J Mol Graph Model (2010) 0.92
Identification of novel functional inhibitors of acid sphingomyelinase. PLoS One (2011) 0.91
Qualitative prediction of blood-brain barrier permeability on a large and refined dataset. J Comput Aided Mol Des (2011) 0.89
Getting the MAX out of Computational Models: The Prediction of Unbound-Brain and Unbound-Plasma Maximum Concentrations. ACS Med Chem Lett (2012) 0.75
A Genetic Algorithm Based Support Vector Machine Model for Blood-Brain Barrier Penetration Prediction. Biomed Res Int (2015) 0.75
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature (2001) 11.78
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem (2000) 6.87
L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. Biochemistry (2000) 2.36
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos (1999) 2.02
A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats. Pharmacol Biochem Behav (2000) 1.93
Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. Drug Metab Dispos (2000) 1.87
Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery. Biopharm Drug Dispos (2002) 1.71
Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm Res (1999) 1.70
Functional group contributions to drug-receptor interactions. J Med Chem (1984) 1.70
Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J Pharm Sci (1999) 1.55
The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model. Drug Metab Dispos (2004) 1.43
Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1-receptor antagonist with negligible ability to penetrate the central nervous system. Br J Pharmacol (1986) 1.43
The metabolism and distribution of the selective adrenergic beta blocking agent, practolol. J Pharmacol Exp Ther (1970) 1.40
Pharmacokinetics, central nervous system uptake, and lipid solubility of propranolol, acebutolol, and sotalol. Cardiology (1984) 1.37
Expression analysis of BACE2 in brain and peripheral tissues. J Biol Chem (2000) 1.36
Lipophilicity in PK design: methyl, ethyl, futile. J Comput Aided Mol Des (2001) 1.22
Metabolism and kinetics of bupropion. J Clin Psychiatry (1983) 1.22
Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. J Med Chem (1988) 1.18
Modeling blood-brain barrier partitioning using the electrotopological state. J Chem Inf Comput Sci (2002) 1.14
Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology (2000) 1.14
Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline. Neuropharmacology (1990) 1.13
A widely applicable set of descriptors. J Mol Graph Model (2000) 1.12
Predicting CNS permeability of drug molecules: comparison of neural network and support vector machine algorithms. J Comput Biol (2002) 1.10
Designing libraries with CNS activity. J Med Chem (1999) 1.09
Predicting blood-brain barrier permeation from three-dimensional molecular structure. J Med Chem (2000) 1.07
Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2'-(14)C]nicotine. Drug Metab Dispos (2001) 1.06
Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. J Pharmacol Exp Ther (1989) 1.06
beta-Adrenoreceptor-blocking agents and the blood-brain barrier. Clin Sci (Lond) (1980) 1.03
Lipophilicity and brain disposition of clonidine and structurally related imidazolidines. Naunyn Schmiedebergs Arch Pharmacol (1977) 1.03
Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity. J Pharmacol Exp Ther (1989) 1.02
Cocaine and alcohol interactions in the rat: contribution of cocaine metabolites to the pharmacological effects. J Pharm Sci (1999) 0.98
Computation of brain-blood partitioning of organic solutes via free energy calculations. J Med Chem (1996) 0.97
Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors. J Neurochem (1997) 0.97
Blood-brain barrier permeation models: discriminating between potential CNS and non-CNS drugs including P-glycoprotein substrates. J Chem Inf Comput Sci (2004) 0.96
Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. J Pharm Sci (1994) 0.96
Critical factors of intracerebral microdialysis as a technique to determine the pharmacokinetics of drugs in rat brain. Brain Res (1994) 0.95
P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine. J Pharm Sci (2003) 0.95
Characterization of the receptor mediating the nicotine discriminative stimulus. Psychopharmacology (Berl) (1981) 0.92
Prediction of the brain-blood distribution of a large set of drugs from structurally derived descriptors using partial least-squares (PLS) modeling. J Chem Inf Comput Sci (1999) 0.91
Predicting blood-brain barrier partitioning of organic molecules using membrane-interaction QSAR analysis. Pharm Res (2002) 0.91
Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat. Drug Metab Dispos (1999) 0.91
Correlation and prediction of a large blood-brain distribution data set--an LFER study. Eur J Med Chem (2001) 0.90
Recent advances in the prediction of blood-brain partitioning from molecular structure. J Pharm Sci (2003) 0.90
Prediction of drug transport processes using simple parameters and PLS statistics. The use of ACD/logP and ACD/ChemSketch descriptors. Eur J Pharm Sci (2001) 0.89
Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats. J Pharmacol Exp Ther (1986) 0.89
Influence of multidrug resistance (MDR) proteins at the blood-brain barrier on the transport and brain distribution of enaminone anticonvulsants. J Pharm Sci (2001) 0.89
Nicotine is more efficient than cotinine at passing the blood-brain barrier in rats. Cell Mol Neurobiol (1998) 0.88
In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents. J Pharm Sci (1998) 0.88
Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats. Eur J Pharmacol (2000) 0.87
Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity. Psychopharmacology (Berl) (1987) 0.87
Theoretical calculation and prediction of brain-blood partitioning of organic solutes using MolSurf parametrization and PLS statistics. J Pharm Sci (1998) 0.87
Uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats: intravenous infusion studies. J Pharmacol Exp Ther (1990) 0.86
Metabolism and disposition of trifluoperazine in the rat. II. Kinetics after oral and intravenous administration in acutely and chronically treated animals. Drug Metab Dispos (1977) 0.86
Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis. Pharm Res (1996) 0.86
Microdialysis studies of the distribution of stavudine into the central nervous system in the freely-moving rat. Pharm Res (1997) 0.85
ADME evaluation in drug discovery. 1. Applications of genetic algorithms to the prediction of blood-brain partitioning of a large set of drugs. J Mol Model (2002) 0.85
Building predictive ADMET models for early decisions in drug discovery. Curr Opin Drug Discov Devel (2004) 0.85
Tissue distribution of ibuprofen in a fatal overdose. Am J Forensic Med Pathol (1993) 0.84
Tissue distribution of terbinafine in rats. J Pharm Sci (2001) 0.84
Blood to brain distribution of neuroleptics. Psychiatry Res (1987) 0.83
Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship. Br J Pharmacol (1992) 0.83
Drug distribution between blood and brain as a determinant of antipsychotic drug effects. Biol Psychiatry (1992) 0.82
Phosphatidylserine as a determinant for the tissue distribution of weakly basic drugs in rats. Pharm Res (1990) 0.82
Pharmacokinetics and distribution over the blood-brain barrier of zalcitabine (2',3'-dideoxycytidine) and BEA005 (2', 3'-dideoxy-3'-hydroxymethylcytidine) in rats, studied by microdialysis. Antimicrob Agents Chemother (1998) 0.82
Drug distribution studies with microdialysis: I. Tissue dependent difference in recovery between caffeine and theophylline. Life Sci (1991) 0.81
Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine. Brain Res Dev Brain Res (1993) 0.81
Quantitative whole-body autoradiographic determination of tacrine tissue distribution in rats following intravenous or oral dose. Pharm Res (1989) 0.81
Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat. Psychopharmacology (Berl) (1998) 0.80
Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.80
Interaction of triazolam and ketoconazole in P-glycoprotein-deficient mice. Drug Metab Dispos (2004) 0.79
Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: a quantitative microdialysis study. J Pharmacol Exp Ther (1995) 0.79
Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats. J Pharmacol Exp Ther (1981) 0.78
Stability, human blood distribution and rat tissue localization of promazine and desmonomethylpromazine. Biopharm Drug Dispos (1990) 0.78
Blood-brain barrier permeability and in vivo activity of partial agonists of benzodiazepine receptor: a study of L-663,581 and its metabolites in rats. J Pharmacol Exp Ther (1994) 0.78
High-throughput prediction of blood-brain partitioning: a thermodynamic approach. J Chem Inf Comput Sci (2001) 0.78
The mode of action of analgesic drugs in adjuvant arthritic rats as an experimental model of chronic inflammatory pain: possible central analgesic action of acidic nonsteroidal antiinflammatory drugs. Jpn J Pharmacol (1984) 0.78
Imipramine and its metabolites: relationship to cerebral catecholamines in rats in vivo. J Pharmacol Exp Ther (1984) 0.77
Human brain, plasma, and cerebrospinal fluid concentration of sodium valproate after 72 hours of therapy. Neurology (1981) 0.77
Determination and pharmacokinetic profile of omeprazole in rat blood, brain and bile by microdialysis and high-performance liquid chromatography. J Chromatogr A (2002) 0.77
Drug distribution as a function of binding competition. Experiments with the distribution dialysis technique. J Pharm Pharmacol (1980) 0.77
Design, synthesis and biological evaluation of a novel series of potent, orally active adenosine A1 receptor antagonists with high blood-brain barrier permeability. Chem Pharm Bull (Tokyo) (2001) 0.76
Effect of age, body composition, and lipid solubility on benzodiazepine tissue distribution in rats. Arzneimittelforschung (1987) 0.76
Detection of fluoxetine in brain, blood, liver and hair of rats using gas chromatography-mass spectrometry. Life Sci (1999) 0.76
E-state modeling of dopamine transporter binding. Validation of the model for a small data set. J Chem Inf Comput Sci (2000) 0.75
Pharmacokinetic aspects of elimination from plasma and distribution to brain and liver of barbiturates in rat. Chem Pharm Bull (Tokyo) (1973) 0.75
Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity. J Pharmacol Exp Ther (2001) 0.75
The effect of aluminium chloride upon the transition of drugs through the blood-brain barrier into the central nervous system. Eur J Drug Metab Pharmacokinet (1992) 0.75
Interaction between probenecid and two lipid-soluble barbiturates in the rat. Neuropharmacology (1984) 0.75
Reevaluation of potency and pharmacokinetic properties of some lipid-soluble barbiturates with an EEG-threshold method. Acta Pharmacol Toxicol (Copenh) (1984) 0.75
Metabolism, distribution and excretion of the thiophthalane lu 5-003, a bicyclic thymoleptic. Acta Pharmacol Toxicol (Copenh) (1970) 0.75
In vivo disposition and in vitro metabolism of an anxiolytic compound, BMS-184111, in rats. Res Commun Mol Pathol Pharmacol (1995) 0.75
The relationship between the pharmacological effect of amitriptyline based on an improved forced-swimming test and plasma concentration in rats. Biol Pharm Bull (1995) 0.75
Comparative studies on distribution, excretion, and metabolism of hydroxyzine-3H and its methiodide-14C in rats. J Pharm Sci (1974) 0.75
Predicting the brain-penetrating capability of histaminergic compounds. Drug Des Discov (1994) 0.75
Dispositional study of opioids in mice pretreated with sympathomimetic agents. J Pharm Pharmacol (1992) 0.75
Effect of concanavalin A on the aspirin concentration and distribution in the brain and plasma of rats. J Pharmacobiodyn (1986) 0.75
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev (2001) 36.00
Prevalence of SOD1 mutations in the Italian ALS population. Neurology (2008) 2.60
The in-vitro effects of nicotine and cotinine on sperm motility. Hum Reprod (1997) 1.53
Trapping cDNAs encoding secreted proteins from the salivary glands of the malaria vector Anopheles gambiae. Proc Natl Acad Sci U S A (1999) 1.48
The effect of adding nitrous oxide on MAC of sevoflurane combined with two target-controlled concentrations of remifentanil in women. Eur J Anaesthesiol (2005) 1.46
Early laparoendoscopic rendezvous for acute biliary pancreatitis: preliminary results. Surg Endosc (2009) 1.44
Long-lasting catch-up growth under bio-methionyl growth hormone treatment in an infant with isolated growth hormone deficiency type 1A. Acta Paediatr Scand (1991) 1.38
Wolfram syndrome and WFS1 gene. Clin Genet (2010) 1.20
Migration of metallic clips used during laparoscopic cholecystectomy and formation of gallstones around them: surgical implications from a prospective study. J Laparoendosc Adv Surg Tech A (1997) 1.16
Full-term pregnancies achieved with ICSI despite high levels of sperm chromatin damage. Hum Reprod (2004) 1.13
Risk assessment and prediction of rebleeding in bleeding gastroduodenal ulcer. Endoscopy (2002) 1.13
Study of apoptotic DNA fragmentation in human spermatozoa. Hum Reprod (2000) 1.13
A cluster of four D7-related genes is expressed in the salivary glands of the African malaria vector Anopheles gambiae. Insect Mol Biol (2002) 1.10
Bucrylate treatment of bleeding gastric varices: 12 years' experience. Endoscopy (2000) 1.04
Endoscopic clipping of anastomotic leakages in esophagogastric surgery. Endoscopy (1998) 1.01
Placebo-controlled, double-blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod (1993) 1.01
Effects of prolonged autovehicle driving on male reproduction function: a study among taxi drivers. Am J Ind Med (1996) 1.00
All classifications not built on pathogenesis become inadequate sooner or later. Diabetologia (2011) 0.99
Correlation between ejaculatory and erectile dysfunction. Int J Androl (2005) 0.99
Stress, sexual dysfunctions, and male infertility. J Endocrinol Invest (2003) 0.96
Liver glycogenosis as early manifestation in type 1 diabetes mellitus. Diabetes Nutr Metab (2003) 0.94
Glutathione treatment of dyspermia: effect on the lipoperoxidation process. Hum Reprod (1994) 0.93
Large foreign body as a nidus for a common duct stone in a patient without spontaneous biliary enteric fistula or previous abdominal surgery. HPB Surg (1993) 0.93
HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin. J Neurol Neurosurg Psychiatry (2007) 0.93
Nuclear chromatin variations in human spermatozoa undergoing swim-up and cryopreservation evaluated by the flow cytometric sperm chromatin structure assay. Mol Hum Reprod (1999) 0.93
Chromosomal alterations and male infertility. J Endocrinol Invest (2000) 0.92
CT features of malignant mucinous cystic tumors of the pancreas. Eur Radiol (2001) 0.91
Positive selection drives accelerated evolution of mosquito salivary genes associated with blood-feeding. Insect Mol Biol (2013) 0.91
Congenital adenohypophysis aplasia: clinical features and analysis of the transcriptional factors for embryonic pituitary development. J Endocrinol Invest (2006) 0.89
TIPS allowing for an endoscopic mucosal resection of early gastric cancer in a cirrhotic patient with severe hypertensive gastropathy: report of a case. Surg Today (1999) 0.88
Subclinical hypothyroidism: the state of the art. J Endocrinol Invest (2008) 0.88
Cryopreservation and sperm DNA integrity. Cell Tissue Bank (2006) 0.87
MDCT of blunt renal trauma: imaging findings and therapeutic implications. Insights Imaging (2015) 0.86
Lymphocyte subsets in multiple sclerosis. A study with two-colour fluorescence analysis. J Neurol Sci (1996) 0.86
Glucose tolerance, insulin secretion and peripheral sensitivity in thalassaemia major. J Pediatr Endocrinol Metab (1998) 0.84
Testicular cancer and sperm DNA damage: short- and long-term effects of antineoplastic treatment. Andrology (2014) 0.84
Immature germ cell separation using a modified discontinuous Percoll gradient technique in human semen. Hum Reprod (1999) 0.84
Fertility and semen quality of workers exposed to high temperatures in the ceramics industry. Reprod Toxicol (1992) 0.84
Endoscopic treatment of esophageal granular cell tumors. Endoscopy (2002) 0.84
Serum anti-p53 autoantibodies in patients with type 1 diabetes. Ann Clin Lab Sci (2001) 0.83
Effects of high-dose vitamin E supplementation on oxidative stress and microalbuminuria in young adult patients with childhood onset type 1 diabetes mellitus. Diabetes Metab Res Rev (2007) 0.83
Recurrent acute pancreatitis: an additional manifestation of the "wandering spleen" syndrome". Am J Gastroenterol (1996) 0.83
Factors affecting diabetes mellitus onset in cystic fibrosis: evidence from a 10-year follow-up study. Acta Paediatr (1999) 0.83
Association of five autoimmune diseases in a young woman with Down's syndrome. J Endocrinol Invest (2009) 0.83
At the interface between parasite and host: the salivary glands of the African malaria vector Anopheles gambiae. Parassitologia (2006) 0.83
[On a case of dermatomyositis associated with esophageal neoplasm]. Minerva Med (1968) 0.82
[The rheological and biohumoral picture in normal and pathological pregnancy]. Minerva Ginecol (1982) 0.82
No changes of insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study. Eur J Endocrinol (1994) 0.82
Polyunsaturated fatty acids of germ cell membranes, glutathione and blutathione-dependent enzyme-PHGPx: from basic to clinic. Contraception (2002) 0.82
Androgen receptor polymorphisms and testicular cancer risk. Andrology (2014) 0.82
Salivary gland-specific gene expression in the malaria vector Anopheles gambiae. Parassitologia (1999) 0.82
Health-related quality of life and treatment preferences in adolescents with type 1 diabetes. The VIPKIDS study. Acta Diabetol (2013) 0.82
Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis. Eur J Endocrinol (1999) 0.81
Metabolic and clinical events preceding diabetes mellitus onset in cystic fibrosis. Eur J Endocrinol (1996) 0.81
[Radiology of the foot in chronic alcoholism]. Radiol Med (1988) 0.81
Relationships between neuroradiological and clinical features in apparently idiopathic hypopituitarism. Eur J Endocrinol (1998) 0.81
The effect of adding two target-controlled concentrations (1-3 ng mL -1 ) of remifentanil on MAC BAR of desflurane. Eur J Anaesthesiol (2006) 0.81
Final height in isolated GH deficiency type 1A: effects of 5-year treatment with IGF-I. Eur J Endocrinol (2001) 0.80
Intestinal anisakiasis in Italy: case report. J Helminthol (2004) 0.80
Clip migration within the common duct after laparoscopic cholecystectomy: a case of transient acute pancreatitis in the absence of associated stones. Endoscopy (1997) 0.80
Aldosterone synthase deficiency type I with no documented homozygous mutations in the CYP11B2 gene. Eur J Endocrinol (2001) 0.80
Laser radiation and motility patterns of human sperm. Arch Androl (1989) 0.80
Antisperm antibody detection: 2. Clinical, biological, and statistical correlation between methods. Am J Reprod Immunol (1997) 0.79
Interventional treatment of sialoliths in main salivary glands. Radiol Med (2002) 0.79
Unilateral cryptorchidism corrected in prepubertal age: evaluation of sperm parameters, hormones, and antisperm antibodies in adult age. Fertil Steril (1997) 0.79
Semen quality in men with Y chromosome aberrations. Int J Androl (2010) 0.79
T-cell interleukin-6 receptor binding in interferon-beta-1b-treated multiple sclerosis patients. Eur J Neurol (2000) 0.79
Computer assisted sperm motility analysis at the moment of induced pregnancy during gonadotropin treatment for hypogonadotropic hypogonadism. J Endocrinol Invest (1993) 0.78
Myth and reality of the decline in semen quality: an example of the relativity of data interpretation. J Endocrinol Invest (2000) 0.78
Three-year prospective evaluation of glucose tolerance, beta-cell function and peripheral insulin sensitivity in non-diabetic patients with thalassemia major. J Endocrinol Invest (2002) 0.78
Impact of Italian legislation regulating assisted reproduction techniques on ICSI outcomes in severe male factor infertility: a multicentric survey. Hum Reprod (2007) 0.78
Immunological infertility in humans. Exp Clin Immunogenet (1993) 0.78
Sudden Sensorineural Hearing Loss: MR Imaging. Neuroradiol J (2010) 0.77
Study of antisperm antibodies bound to the sperm cell surface and their relationship to circulating ASA. Am J Reprod Immunol (1995) 0.77
Computer assisted sperm motility analysis. Acta Eur Fertil (1992) 0.77
Increased T-lymphocyte interleukin-6 binding in patients with multiple sclerosis. Eur J Neurol (2000) 0.77
Tahini, a little known sesame-containing food, as an unexpected cause of severe allergic reaction. J Investig Allergol Clin Immunol (2006) 0.77
Protamine-1 and -2 polymorphisms and gene expression in male infertility: an Italian study. J Endocrinol Invest (2011) 0.77
[Regeneration of the neural retina in adult anurian amphibians]. Arch Ital Anat Embriol (1969) 0.77
Glutathione therapy for male infertility. Arch Androl (1992) 0.77
Combined treatment with ketoconazole and cyproterone acetate in a boy with McCune-Albright syndrome and peripheral precocious puberty. J Endocrinol Invest (2008) 0.77
Antisperm antibody detection: 1. Methods and standard protocol. Am J Reprod Immunol (1997) 0.77
Effects of moderate-severe exercise on blood glucose in Type 1 diabetic adolescents treated with insulin pump or glargine insulin. J Endocrinol Invest (2009) 0.77
Prostacyclin for secondary pulmonary hypertension. Ann Intern Med (2000) 0.77
Classification of gallstones and epidemiologic studies. Dig Dis Sci (1995) 0.76
Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism. J Endocrinol Invest (2010) 0.76
Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism. J Endocrinol Invest (2009) 0.76
T-cell interferon gamma receptor binding in interferon beta-1b-treated patients with multiple sclerosis. Arch Neurol (1999) 0.76
Decreases in T-cell tumor necrosis factor alpha binding with interferon beta treatment in patients with multiple sclerosis. Arch Neurol (1999) 0.76
Bilateral hairy polyp of the oropharynx. J Laryngol Otol (1996) 0.76
Final height outcome of growth hormone-deficient patients treated since less than five years of age. Acta Paediatr (1996) 0.75
[Metabolism and action of L-carnitine: its possible role in sperm tail function]. Arch Ital Urol Nefrol Androl (1992) 0.75
Very late immune response to growth hormone (GH) therapy in an infant with GH-N gene deletion. Acta Paediatr (1992) 0.75
Hypercalcemia, calcium in bile, and calcium in gallstones. Gastroenterology (1995) 0.75
The possible role of phospholipase in gallstone pathogenesis. Gastroenterology (1991) 0.75
Hepatolithiasis and cholesterol and bile acid metabolism. Gastroenterology (1996) 0.75
Cobalamin status in sickle cell disease. Int J Lab Hematol (2012) 0.75
Novel mutation of CYP21A2 gene (N387K) affecting a non-conserved amino acid residue in exon 9. J Endocrinol Invest (2009) 0.75